I can appreciate it could be Purdue regarding patent royalty fees or Pfizer in the broad sense of exclusivity rights. I should have been more clear. Pfizer has no leg to stand on regarding patent rights regarding formulation. Clearly they do on exclusivity rights but only regarding Troxyca. Pfizer has no exclusivity rights regarding Embeda whatsoever any longer to my knowledge.
News 
Market Data 
Discover 
AI
